# CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

> **NCT00892866** · NA · ACTIVE_NOT_RECRUITING · sponsor: **GOG Foundation** · enrollment: 877 (estimated)

## Conditions studied

- Atypical Endometrial Hyperplasia
- Human Papillomavirus Infection
- Stage 0 Cervical Cancer AJCC v7

## Interventions

- **OTHER:** Cytology Specimen Collection Procedure
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT00892866
- **Lead sponsor:** GOG Foundation
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-04-13
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 877 (ESTIMATED)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00892866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00892866, "CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00892866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*